SMTI

Sanara MedTech Inc. (SMTI) | Rumor.io

Sanara MedTech

SMTI

Attention (50-day avg)0%

Attention rank (50-day avg)#4,450

Bullish sentiment (50-day avg)84%

Price to earnings ratio58.2

Market capitalization322.5M

Earnings per share-0.04

Dividend yield (TTM)—

Revenue (annual)103.1M

Net income (annual)-37.6M

Social

What share of all stock conversation is about SMTI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Jul 29

Sanara MedTech Inc. ($SMTI) has been acquired by MiMedx Group, Inc. ($MDXG) for $35 per share, with a total enterprise value of approximately $350 million.
The acquisition includes a cash payment of $33.00 per share plus 0.4735 shares of MiMedx common stock.
The deal is expected to double MiMedx's surgical revenue and accelerate growth and profitability.

Generated by AI

Sentiment

Of the messages about SMTI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	88.15% -7.97
Bearish	—	—	—	11.85% +7.97

Topics

Of the messages about SMTI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	36.07%
Technical Analysis	—	—	—	9.84%
Analysts	—	—	—	22.48%
Controversies	—	—	—	0%
Earnings	—	—	—	6.32%
Macro	—	—	—	25.29%

Community

Of the messages about SMTI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	95.22%
Newcomers	—	—	—	4.78%

Jul 29

Newcomers to Sanara MedTech Inc. ($SMTI) are focused on the company's acquisition by MiMedx Group ($MDXG) for $35 per share, with some expressing disappointment at the value.
The acquisition deal is valued at approximately $350 million, with a total enterprise value of $279 million, and will result in a significant increase in surgical revenue for MiMedx.
Some investors are also discussing their personal experiences with buying and selling $SMTI, including one user who made a profit of $245.50 after selling their shares at $33.45.

Generated by AI

News

Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx

Tipranks Press Release.

24d agoThe Globe and Mail

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior competing offers. ...

1mo agoBarchart.com

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

1mo agoYahoo Finance

Sanara Medtech earnings missed by $0.02, revenue fell short of estimates

1mo agoInvesting.com

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Summary(1) ●Net revenue increased 9% to $28.1 milli

1mo agoYahoo Finance

H.C. Wainwright cuts Sanara MedTech stock rating on acquisition deal

2mo agoInvesting.com

Also Discussed

Investors talking about SMTI also mention

#	Name	Attention
1	XPEL Inc.XPEL	0%0
2	Red Violet, Inc.RDVT	0%0
3	Ascent Industries Co.ACNT	0%new
4	SOBR Safe, Inc.SOBR	0%0
5	Semtech CorporationSMTC	0.01%-0.14
6	InTest CorporationINTT	0%new
7	J.B. Hunt Transport Services, Inc.JBHT	0%new
8	Inhibikase Therapeutics, Inc.IKT	0%new
9	Regis Corp.RGS	0%new
10	Wix.com Ltd.WIX	0%new

Sanara MedTech Inc.

Healthcare
Medical Instruments & Supplies

Sanara MedTech Inc. is a medical technology company that develops, markets, and distributes surgical, wound care, and skin care solutions for physicians, hospitals, clinics, and post-acute care providers. Its portfolio includes products used in surgical tissue repair, advanced wound management, infection control, and skin cleansing, supporting clinical workflows across a range of care settings. The company focuses on evidence-based technologies designed to help improve healing outcomes and address complex tissue health needs. Sanara MedTech Inc. serves healthcare professionals in the United States through a product mix that spans surgical adjuncts, biologic materials, wound care devices, and antimicrobial cleansers. Based in Fort Worth, Texas, Sanara MedTech Inc. plays a role in the medical products market by supplying specialized solutions for surgical and chronic wound treatment.

Website

Location

1200 Summit Avenue

Fort Worth, TX, 76102

United States

Sanara MedTech

Social

Jul 29

Jul 29

Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara Medtech earnings missed by $0.02, revenue fell short of estimates

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

H.C. Wainwright cuts Sanara MedTech stock rating on acquisition deal

Also Discussed

Sanara MedTech Inc.

Company Information

Location

Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara Medtech earnings missed by $0.02, revenue fell short of estimates

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

H.C. Wainwright cuts Sanara MedTech stock rating on acquisition deal

Also Discussed

Social

Jul 29

Jul 29